HOF Capital
Founded in 2016, HOF Capital is a global venture capital firm with $1 billion in assets under management. It invests in ambitious entrepreneurs across various stages, from idea to IPO, focusing on enterprise software, artificial intelligence, frontier tech, consumer, and fintech sectors.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Newfoundland
Sequence Bio
Seed Round in 2019
Sequence Bio is a biotechnology company focused on advancing drug discovery and development through genome therapy. Leveraging the unique genetic characteristics of isolated populations, particularly those in Newfoundland, the company collects DNA and health information to enhance the identification of drug targets. This approach aims to improve the treatment of complex and inherited diseases, ultimately addressing the high failure rate of drug candidates and expediting access to effective therapies for patients in need. By utilizing genetic insights, Sequence Bio seeks to transform the landscape of medicine and deliver better health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.